ANTARES PHARMA, INC.
EWING, NJ

ANTARES PHARMA, INC., Ewing

Company Overview Antares Pharma is a revenue-generating, product focused, specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Antares Pharma products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors. Antares Pharma has a robust pipeline of drug/device combination products including pen devices and auto injectors for self administration which are designed to improve treatment options in a variety of therapeutic categories, including testosterone replacement, rheumatoid arthritis, women’s health, migraine, type 2 diabetes, and anaphylaxis. Class leading device technology platforms, such as our Vibex, QuickShot, and pen device platforms, combined with safe and effective therapies have the potential to improve both patient outcomes and convenience with reliable, accurate, patient-friendly treatment options. Antares Pharma continues to build its commercial portfolio, with four products approved by the FDA in less than 5 years, focusing on innovative, patient-focused therapeutic options. Our marketed products include Otrexup™, Sumatriptan autoinjector, Zoma-Jet and Gelnique, and are built on our proven auto injector and pen device platforms. In addition to our core device platforms, our internal development team specializes in creating custom designed devices that fit the device to the patient and therapeutic need. Founded in 1978 and listed on NASDAQ in 2012, Antares Pharma is focused on value-driven growth and accountability to our shareholders. Complete corporate financial information can be found With over 75 years of combined development experience in-house, Antares Pharma is your turn-key specialty pharmaceutical partner with expertise supporting all aspects of drug and device development. Our business is rooted in a tailored approach to creating products that meet user requirements supported by a flexible business model that creates long-lasting alliances that delivers innovative and approvable combination products. This Site ©2013-2018 Antares Pharma. All Rights Reserved This Site ©2013-2018 Antares Pharma. All Rights Reserved

KEY FACTS ABOUT ANTARES PHARMA, INC.

Company name
ANTARES PHARMA, INC.
Status
Active
Filed Number
F15000005453
FEI Number
41-1350192
Date of Incorporation
December 10, 2015
Age - 9 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://antarespharma.com
Phones
(609) 359-3020
(763) 475-7700

ANTARES PHARMA, INC. NEAR ME

Principal Address
100 Princeton South Corporate Ctr,
Suite 300,
Ewing,
NJ,
08628,
US

See Also

Officers and Directors

The ANTARES PHARMA, INC. managed by the three persons from Ewing on following positions: Dire, President

Helen Torley

Position
Dire Active
From
Ewing, NJ, 08628

Vnicole Labrosse,

Position
Dire Active
From
Ewing, NJ, 08628

Helen Torley

Position
President Active
From
Ewing, NJ, 08628





Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Annual Reports

2023
April 28, 2023
2022
April 6, 2022